This cluster of papers focuses on the study, detection, monitoring, and reporting of adverse drug reactions (ADRs) through pharmacovigilance. It covers various aspects such as signal detection, drug safety surveillance, data mining techniques, patient reporting, regulatory actions, causality assessment, and the impact of ADRs on hospital admissions.